{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:23:41Z","timestamp":1785500621236,"version":"3.56.0"},"reference-count":53,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Streptococcus pyogenes, Streptococcus agalactiae and Streptococcus dysgalactiae subsp. equisimilis (SDSE) are the beta-hemolytic streptococci species with the most clinical relevance to humans. These species are responsible for several infections, ranging from mild to life-threatening diseases. Although resistance to recommended drugs has not been so critical as detected in other species, it has occurred in diverse regions. In Brazil, it is possible to observe an increasing macrolide and lincosamide resistance trend due to the spread of polyclonal strains. Macrolide\u2013lincosamide\u2013streptogramin B (MLS) resistance phenotypes have been prevalent among S.\u00a0agalactiae and S.\u00a0pyogenes, while M phenotype (resistance only to macrolides) has prevailed among SDSE resistant isolates. Fluoroquinolone resistance is rare in this country, reported only in S.agalactiae and S.pyogenes. This is due to nucleotide substitutions in gyrA and parC genes. Reduced penicillin susceptibility and vancomycin resistance, detected in other regions, have not yet been reported in Brazil. Tetracycline is not a therapeutical option, and resistance has occurred at high levels, especially among S.agalactiae. These findings highlight the need for continuous monitoring in order to track the occurrence of antimicrobial resistance among beta-hemolytic streptococci species circulating in this country.<\/jats:p>","DOI":"10.3390\/antibiotics10080973","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T10:54:41Z","timestamp":1628765681000},"page":"973","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Antimicrobial Resistance among Beta-Hemolytic Streptococcus in Brazil: An Overview"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2440-7844","authenticated-orcid":false,"given":"Rosana Rocha","family":"Barros","sequence":"first","affiliation":[{"name":"Departamento de Microbiologia e Parasitologia, Instituto Biom\u00e9dico, Universidade Federal Fluminense, Niter\u00f3i 24210-130, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Haenni, M., Lupo, A., and Madec, J.Y. (2018). Antimicrobial resistance in Streptococcus spp. Microbiol. Spectr., 6.","DOI":"10.1128\/microbiolspec.ARBA-0008-2017"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/cid\/cis847","article-title":"Clinical practice guidelines for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Disease Society of America","volume":"55","author":"Schulman","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion (2020). Prevention of group B streptococcal early-onset disease in newborns. Obstet. Gynecol., 135, e51\u2013e72.","DOI":"10.1097\/AOG.0000000000003668"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e01515-20","DOI":"10.1128\/AAC.01515-20","article-title":"Fluoroquinolone versus beta-lactam oral step-down therapy for uncomplicated streptococcal bloodstream infections","volume":"64","author":"Arensman","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/AAC.00185-08","article-title":"First molecular characterization of group B streptococci with reduced penicillin susceptibility","volume":"52","author":"Kimura","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1093\/jac\/dkw320","article-title":"Description and characterization of a penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis clone isolated from blood in three epidemiologically linked patients.","volume":"71","author":"Fuursted","year":"2016","journal-title":"J. Antimicrobiol. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cid\/ciz1000","article-title":"Streptococcus pyogenes pbp2x mutation confers reduced susceptibility to \u03b2-lactam antibiotics","volume":"71","author":"Vannice","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ijantimicag.2019.08.019","article-title":"A novel genomic island harbouring lsa (E) and lnu (B) genes and a defective prophage in a Streptococcus pyogenes isolate resistant to lincosamide, streptogramin A and pleuromutilin antibiotics","volume":"54","author":"Berbel","year":"2019","journal-title":"Intern. J. Antimicrob. Agents"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1128\/AAC.47.11.3605-3609.2003","article-title":"First Streptococcus agalactiae isolates highly resistant to quinolones with point mutations in gyr A and par C","volume":"47","author":"Kawamura","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/jac\/dki011","article-title":"Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes","volume":"55","author":"Lammens","year":"2005","journal-title":"J. Antimicrobiol. Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2005.12.006","article-title":"Characterization of fluoroquinolone-resistant h-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: Report from the SENTRY Antimicrobial Surveillance Program (1997\u20132004)","volume":"55","author":"Biedenbach","year":"2006","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMc1308504","article-title":"Two cases of invasive vancomycin-resistant group B streptococcus infection","volume":"370","author":"Park","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_13","unstructured":"(2021, June 14). Instituto Brasileiro de Geografia e Estat\u00edstica, Available online: https:\/\/www.ibge.gov.br\/apps\/populacao\/projecao\/index.html."},{"key":"ref_14","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica (2020). T\u00e1bua Completa de Mortalidade Para o Brasil 2019, IBGE."},{"key":"ref_15","unstructured":"(2021, May 18). Minist\u00e9rio da Sa\u00fade do Brasil, Available online: https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/gm\/2020\/prt0264_19_02_2020.html."},{"key":"ref_16","unstructured":"(2021, May 24). Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria\u2014Anvisa, Available online: https:\/\/www.gov.br\/ptbr\/servicos\/consultar-dados-de-vendas-de-medicamentos-controlados-antimicrobianos-e-outros."},{"key":"ref_17","unstructured":"Minist\u00e9rio da Sa\u00fade do Brasil (2013). Aten\u00e7\u00e3o Ao Pr\u00e9-Natal de Baixo Risco, Minist\u00e9rio da Sa\u00fade. [1st ed.]."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1099\/jmm.0.05278-0","article-title":"Susceptibility to antimicrobials and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae from Rio de Janeiro, Brazil","volume":"52","author":"Barros","year":"2003","journal-title":"J. Med. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1128\/AAC.49.1.97-103.2005","article-title":"Distribution of antimicrobial resistance and virulence-related genes among Brazilian Group B Streptococci recovered from bovine and human sources","volume":"49","author":"Duarte","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/S0074-02762011000200001","article-title":"Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae","volume":"106","author":"Nakamura","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1590\/S0074-02762011000800017","article-title":"The genetic diversity and phenotypic characterisation of Streptococcus agalactiae isolates from Rio de Janeiro, Brazil","volume":"106","author":"Correa","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3109\/00365548.2013.810814","article-title":"Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil","volume":"45","author":"Souza","year":"2013","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1128\/JCM.00419-10","article-title":"Phenotypic and genotypic characterization of group B streptococcal isolates in Southern Brazil","volume":"48","author":"Palmeiro","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Otaguiri, E.S., Morguette, A.E., Tavares, E.R., Santos, P.M., Morey, A.T., Cardoso, J.D., Perugini, M.R.E., Yamauchi, L.M., and Yamada-Ogatta, S.F. (2013). Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Parana, Brazil: Capsular types, genotyping, antimicrobial susceptibility and virulence determinants. BMC Microbiol., 13.","DOI":"10.1186\/1471-2180-13-297"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/jac\/dkw085","article-title":"Polyclonal spread of Streptococcus agalactiae resistant to clindamycin among pregnant women in Brazil","volume":"71","author":"Barros","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Dutra, V.G., Alves, V.M.N., Olendzki, A.N., Dias, C.A.G., Bastos, A.F.A., Santos, G.O., Amorim, E.L., Sousa, M.A., Santos, R., and Ribeiro, P.C. (2014). Streptococcus agalactiae in Brazil: Serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-323"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/23744235.2015.1040446","article-title":"Molecular epidemiology of Streptococcus agalactiae recovered from significant bacteriuria","volume":"47","author":"Schuab","year":"2015","journal-title":"Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1590\/S1678-9946201658083","article-title":"Antimicrobial susceptibility of Streptococcus agalactiae isolated from pregnant women","volume":"58","author":"Melo","year":"2016","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bjid.2012.09.006","article-title":"Distribution of serotypes and evaluation of antimicrobial susceptibility among human and bovine Streptococcus agalactiae strains isolated in Brazil between 1980 and 2006","volume":"17","author":"Pinto","year":"2013","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Botelho, A.C.N., Oliveira, J.G., Damasco, A.P., Santos, K.T., Ferreira, A.F.M., Rocha, G.T., Marinho, P.S., Bornia, R.B.G., Pinto, T.C.A., and Am\u00e9rico, M.A. (2018). Streptococcus agalactiae carriage among pregnant women living in Rio de Janeiro, Brazil, over a period of eight years. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196925"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"ID30246","DOI":"10.15448\/1980-6108.2018.3.30246","article-title":"Suscetibilidade antimicrobiana de Streptococcus agalactiae isolados de gestantes em um hospital materno infantil de Porto Alegre, Rio Grande do Sul","volume":"28","author":"Battistin","year":"2018","journal-title":"Sci. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.12998\/wjcc.v8.i18.3988","article-title":"Streptococcus agalactiae: Identification methods, antimicrobial susceptibility, and resistance genes in pregnant women","volume":"8","author":"Santana","year":"2020","journal-title":"World J. Clin. Cases."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bjid.2012.05.003","article-title":"Molecular characterization of the first fluoroquinolone resistant strains of Streptococcus agalactiae isolated in Brazil","volume":"16","author":"Barros","year":"2012","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5216\/rpt.v44i4.39237","article-title":"Avalia\u00e7\u00e3o da coloniza\u00e7\u00e3o por Streptococcus agalactiae em gestantes de alto risco atendidas em Niter\u00f3i-RJ, Brasil","volume":"44","author":"Barros","year":"2015","journal-title":"Rev. Patol. Trop."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/107662903764736382","article-title":"Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil","volume":"9","author":"Barros","year":"2003","journal-title":"Microb. Drug Resist."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1590\/S1413-86702003000100006","article-title":"antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: Results from the PROTEKT surveillance study (1999\u20132000)","volume":"7","author":"Mendes","year":"2003","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/mdr.2010.0162","article-title":"Group A Streptococcus Antibiotic Resistance in Southern Brazil: A 17-Year Surveillance Study","volume":"17","author":"Torres","year":"2011","journal-title":"Microb. Drug Resist."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1590\/0074-0276140231","article-title":"Antimicrobial susceptibility patterns, emm type distribution and genetic diversity of Streptococcus pyogenes recovered in Brazil","volume":"109","author":"Schuab","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1099\/jmm.0.001054","article-title":"Prevalence and long-term persistence of beta- haemolytic streptococci throat carriage among children and young adults","volume":"68","author":"Luiz","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijantimicag.2009.01.012","article-title":"Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations","volume":"34","author":"Smeesters","year":"2009","journal-title":"Intern. J. Antimicrob. Agents"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3855\/jidc.1138","article-title":"Polyclonal dissemination of tetracycline resistance among Streptococcus pyogenes paediatric isolates from Brazil","volume":"4","author":"Smeesters","year":"2010","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1099\/00207713-46-3-774","article-title":"Taxonomic study of Lancefield Streptococcal groups C, G and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov.","volume":"46","author":"Vandamme","year":"1996","journal-title":"Int. J. Syst. Bacteriol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1099\/jmm.0.000052","article-title":"Group C Streptococcus dysgalactiae subsp. equisimilis in south-east Brazil: Genetic diversity, resistance profile and the first report of human and equine isolates belonging to the same multilocus sequence typing lineage","volume":"64","author":"Silva","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/23744235.2016.1192680","article-title":"Antimicrobial susceptibility and genetic relationship among Streptococcus dysgalactiae subsp equismilis isolates in Rio de Janeiro","volume":"48","author":"Souza","year":"2016","journal-title":"Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e00181-19","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial Resistance in ESKAPE Pathogens","volume":"33","author":"Forde","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_46","unstructured":"Centers for Disease Control and Prevention (2019). Antibiotic Resistance Threats in the United States, 2019, U.S. Department of Health and Human Services, CDC."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/JCM.02063-08","article-title":"Practical disk diffusion test for detecting group B Streptococcus with reduced penicillin susceptibility","volume":"47","author":"Kimura","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1700473","DOI":"10.2807\/1560-7917.ES.2018.23.21.1700473","article-title":"The Portuguese Group for the Study of Streptococcal Infections. Increasing macrolide resistance among Streptococcus agalactiae causing invasive disease in non-pregnant adults was driven by a single capsular-transformed lineage, Portugal, 2009 to 2015","volume":"23","author":"Lopes","year":"2018","journal-title":"Eurosurveillance"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Grivea, I.N., Syrogiannopoulos, G.A., Michoula, A.N., Gazeti, G., Malli, E., Tsilipounidaki, K., Fouzas, S., Anthracopoulos, M.B., and Petinaki, E. (2020). emm Types and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece during 2011\u20132017. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0232777"},{"key":"ref_50","unstructured":"Minist\u00e9rio da Sa\u00fade do Brasil (2021, June 01). NOTA INFORMATIVA N\u00ba 9\/2020-SE\/GAB\/SE\/MS, Available online: https:\/\/portalarquivos.saude.gov.br\/images\/pdf\/2020\/May\/21\/Nota-informativa---Orienta----es-para-manuseio-medicamentoso-precoce-de-pacientes-com-diagn--stico-da-COVID-19.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"and the Finnish study group for antimicrobial resistance. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci In Finland","volume":"337","author":"Seppala","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_52","unstructured":"(2021, June 01). Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria\u2014Anvisa, Available online: https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/anvisa\/2011\/rdc0020_05_05_2011.html."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.5713\/ajas.20.0156","article-title":"Bovine mastitis: Risk factors, therapeutic strategies, and alternative treatments\u2014A review","volume":"33","author":"Cheng","year":"2020","journal-title":"Asian-Australas. J. Anim. Sci."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/8\/973\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:44:50Z","timestamp":1760165090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/8\/973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":53,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["antibiotics10080973"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics10080973","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]}}}